Interestingly, we found that its clinical relevance manifested in the levels of HLAs were significantly higher in AML patients than normal individuals in an independent sample cohort (TCGA-AML vs. GTEx) (Figure S10), suggesting their potential roles in leukemia development. The gene discussed is HLA-S; the disease is acute myeloid leukemia.